Related Experiment Video
Updated: Jan 24, 2026

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration
Torbjørn Kråkenes1, Ida Herdlevaer1,2, Margrethe Raspotnig1
1Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Abstract:
The pathogenesis of Yo-mediated paraneoplastic cerebellar degeneration (PCD) is unclear. We applied cerebrospinal fluid and serum from PCD patients as well as CDR2 and CDR2L antibodies to neuronal tissue, cancer cell lines, and cells transfected with recombinant CDR2 and CDR2L to elucidate which is the major antigen of Yo antibodies. We found that Yo antibodies bound endogenous CDR2L, but not endogenous CDR2. However, Yo antibodies can bind the recombinant CDR2 protein used in routine clinical testing for these antibodies. Because Yo antibodies only bind endogenous CDR2L, we conclude that CDR2L is the major antigen of Yo antibodies in PCD. ANN NEUROL 2019;86:316-321.
Insights
Yo antibodies in paraneoplastic cerebellar degeneration (PCD) primarily target the endogenous CDR2L protein, not CDR2. This finding clarifies the major antigen responsible for Yo-mediated PCD pathogenesis.
Area of Science:
- Neuroimmunology
- Onconeural antigens
- Paraneoplastic syndromes
Background:
- Paraneoplastic cerebellar degeneration (PCD) is a rare neurological disorder.
- Yo-associated PCD is frequently linked to specific onconeural antibodies.
- The precise antigen targeted by Yo antibodies remains debated.
Purpose of the Study:
- To identify the primary endogenous antigen recognized by Yo antibodies in PCD.
- To differentiate between CDR2 and CDR2L as the main target of Yo antibodies.
Main Methods:
- Analysis of cerebrospinal fluid and serum from PCD patients.
- Immunohistochemical staining of neuronal tissue and cancer cell lines.
- Testing antibody binding to cells transfected with recombinant CDR2 and CDR2L.
Main Results:
- Yo antibodies demonstrated binding to endogenous CDR2L in neuronal tissues.
- No significant binding of Yo antibodies to endogenous CDR2 was observed.
- Yo antibodies showed reactivity with recombinant CDR2 protein used in clinical assays.
Conclusions:
- CDR2L is identified as the major endogenous antigen targeted by Yo antibodies in PCD.
- The reactivity with recombinant CDR2 in assays may be due to cross-reactivity or altered protein structure.
- This clarifies the immunopathogenesis of Yo-mediated PCD.
Related Concept Videos
Major Organs of the Digestive System
Gastrointestinal tract:
Major Losses in Pipes
Fluid flow can be classified as laminar or turbulent, primarily based on the Reynolds number. This dimensionless number reflects the relative influence of inertial to viscous...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Anatomy of the Brain: Major Regions
The cerebrum is the largest section of the brain and divides into left and right hemispheres, separated by a deep fissure. The cerebral outer layer of grey matter — the cerebral cortex — comprises elevations called gyri and shallow groves called sulci. The inner portion of white matter includes long nerve fibers known as axons, which connect...
Major Somatic Sensory Pathways
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

